Jianyang Feng & Hong He. (2022). Signature of arylacetamide deacetylase expression is associated with prognosis and immune infiltration in ovarian cancer. Korean Society of Obstetrics and Gynecology.
Chicago Style (17th ed.) CitationJianyang Feng and Hong He. Signature of Arylacetamide Deacetylase Expression Is Associated with Prognosis and Immune Infiltration in Ovarian Cancer. Korean Society of Obstetrics and Gynecology, 2022.
MLA (9th ed.) CitationJianyang Feng and Hong He. Signature of Arylacetamide Deacetylase Expression Is Associated with Prognosis and Immune Infiltration in Ovarian Cancer. Korean Society of Obstetrics and Gynecology, 2022.
Warning: These citations may not always be 100% accurate.